ResourcesVendorsNuclear MedicineServicesImaginAb, Inc.423 HINDRY AVE SUITE DeMail:Website:https://www.imaginab.comLatest from ImaginAb, Inc.Industry NewsImaginAB licenses immuno-PET tracer to LeucidBy AuntMinnieEurope.com staff writersImmuno-PET developer ImaginAB has licensed its zirconium-89 crefmirlimab berdoxam radiotracer to biotech company Leucid for use in studies of solid tumors.April 11, 2023Clinical NewsImaginAb secures supply agreement with Genmab A/SBy AuntMinnieEurope.com staff writersImaginAb has signed a multiyear licensing agreement with Genmab to supply the company with its investigational zirconium-89-based PET radiopharmaceutical for use in clinical trials.May 5, 2022Industry NewsImaginAb sets sight on Chinese marketBy AuntMinnieEurope.com staff writersImmuno-PET developer ImaginAb has signed a partnership with DongCheng Pharmaceutical Group with the goal of achieving market authorization in China for cancer imaging radiotracers.January 30, 2022Industry NewsImaginAb signs new agreement with Boehringer IngelheimBy AuntMinnieEurope.com staff writersImaginAb has signed a new license agreement to supply its ImmunoPET radiotracer to Boehringer Ingelheim.July 25, 2021Industry NewsImaginAb appoints new COOBy AuntMinnieEurope.com staff writersImaging agent developer ImaginAb appointed Ian Wilson as its new chief operating officer (COO).February 5, 2018Clinical NewsImaginAb teams with NovotectidBy AuntMinnieEurope.com staff writersImaginAb has inked an exclusive technology development partnership with fellow imaging agent developer Novotectid to develop antibody-based imaging agents to image CD4+ immune T cells.September 16, 2014Clinical NewsImaginAb teams with Danish pharma firmBy AuntMinnieEurope.com staff writersImaging agent developer ImaginAb has inked a collaboration and commercialization agreement with Danish pharmaceutical firm H. Lundbeck.October 8, 2012Industry NewsGE signs PET agent R&D deal with ImaginAbBy AuntMinnieEurope.com staff writersGE Healthcare has signed an R&D deal with ImaginAb to develop new PET radiopharmaceuticals based on ImaginAb's antibody fragment technology.June 6, 2011Clinical NewsImaginAb, GlaxoSmithKline join forcesBy AuntMinnieEurope.com staff writersImaging agent developer ImaginAb and GlaxoSmithKline unit GSK Clinical Imaging Centre have inked two research collaboration agreements.May 19, 2010
